Table 4.
The most used medications for the pharmacological treatment of insomnia disorders in adolescents.
Drugs | Mechanism of action | Effects on sleep architecture | Side effects | Comments |
---|---|---|---|---|
Benzodiazepines • Clonazepam • Flurazepam, • Quazepam • Temazepam • Estazolam • Triazolam |
Agonists of central GABAA receptors | Decreased nocturnal awakenings and suppression of delta sleep | Tolerance, dependence, residual sedation, cognitive or psychomotor disorders, anterograde amnesia, respiratory depression and withdrawal symptoms in case of treatment discontinuation | Short half-life molecules for sleep onset insomnia and long half-life molecules for insomnia maintenance |
Alpha-receptor agonists • Clonidine • Guanfacine |
Decreased release of norepinephrine | Decreased sleep latency | Dry mouth, hypotension, bradycardia and withdrawal symptoms (shortness of breath, hypertension and tachycardia) in case of treatment discontinuation | They may be used in daytime treatment of attention-deficit/hyperactivity disorder |
Benzodiazepines-like • Zolpidem • Zaleplon |
Similar action to benzodiazepines but shorter half-life time | Decreased sleep latency | Similar to benzodiazepines | Very few data on their use in adolescents |
Atypical antidepressants • Trazodone |
Antagonists of serotonin (5-HT2A/c) receptors | Decreased sleep latency, improved sleep continuity, decreased REM sleep and increased delta sleep | Residual sedation, cardiac arrhythmias, hypotension and priapism | They are particularly indicated in cases of comorbid depression |
Antihistamines • Diphenhydramine • Brompheniramine • Chlorpheniramine • Hydroxyzine |
Antagonists of histamine (H1) receptors | Decreased sleep latency | Residual sedation, loss of appetite, nausea, vomiting, constipation, dry mouth, paradoxical excitation and risk of altered sleep quality | They are well accepted by adolescents and their parents |
Melatonin | Targeted action on the circadian regulation of sleep | Reduced sleep latency and correction of some alterations of the circadian rhythm | Largely unknown (hypotension, bradycardia, nausea, headache and possible exacerbations of comorbid autoimmune diseases) | Melatonin may be used in adolescents with mental retardation, pervasive developmental disorders and neurological disorders |
Herbal treatments • Passiflora • Valerian • German chamomile • Kava • Lavender |
Modulation of central GABA receptors activity and induction of central nervous system depression | Potential sleep-promoting effects without residual daytime drowsiness or performance impairment | Largely unknown | The long-term efficacy and safety of herbal treatments are unknown |